Enovis to acquire LimaCorporate for €800M enterprise value

Enovis CORP

Enterprise value €800M: €700M cash at closing + €100M in Enovis common shares within 18 months.
Expected 2024 revenue $290-300M and adjusted EBITDA $70-75M from Lima.
Approximately $40M in cost synergies targeted by year three post-close via supply chain and cost consolidation.
Transaction expected to close early 2024, subject to regulatory approvals; neutral to slightly accretive to 2024 adjusted EPS.
Deal creates ~$1B revenue reconstruction business with ~50% in fast-growing extremities markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.